PHOENIX, Dec. 2, 2019 /PRNewswire-PRWeb/ -- Aesthetics
Biomedical, a company committed to the development and distribution
of innovative aesthetic devices, products, and services for the
global market, announce scientific findings for its proprietary
SoME™ Skincare product. SoME™ is the first of its kind topical
product that provides the vehicle for a personalized autologous
platelet rich plasma (PRP) skincare product for home use. The field
of personalized aesthetics and the use of PRP to effectively
achieve aesthetic outcomes is expanding daily, providing new
opportunities to advance the science. Contributing to this
knowledge base, the results from ABM's controlled, blinded,
eight-week study was recently published in the (J Cosmetic
Dermatology Vol 18,Issue 5, 2019; Dermatology Times Vol 40, Issue
9,2019 ). The data indicated that the proprietary SoME™ cosmetic
base, when combined with autologous PRP, could demonstrate
identifiable clinical improvement for signs of facial aging at four
weeks, with enhanced performance observed at eight weeks (e.g.,
luminosity, radiance, smoothness, reduction in redness and skin
lightening) vs the control base alone. Biopsies revealed enhanced
collagen and elastin expression, including up-regulation of type 1
collagen gene observed with the SoME™ + PRP vs the SoME™ alone.
The proprietary cosmetic base is formulated to preserve viable
platelet function for 90 days. As a point of care product, the
patient visits their physician office, has blood drawn that is
centrifuged to obtain PRP. The PRP is then added to three 1oz
bottles of the SoME™ cosmetic base providing for three months,
twice a day home use. The patient receives a mini-cosmetic
refrigerator to conveniently store the product. The removal of the
product from the refrigerator and applied to the skin provides a
temperature differential that activates the platelets with the
ensuing release of growth factors and other biomolecules. An
additional 120-day study is underway to further verify the clinical
and biochemical findings, and to validate that continued use leads
to further enhanced cosmetic improvement. The product is well
tolerated by all skin types; the preservative system is effective
against bacteria, yeast, and viruses, including HIV. Other
aesthetic treatments can be performed and used concurrently with
SoME™.
"We entered into this PRP treatment arena, realizing that there
was a paucity of controlled studies generating important data
involving PRP, not only for topical use but for aesthetic use in
general. ABM is very focused on conducting critical science that
supports both our topical products and aesthetic devices. Having
the first point of care, autologous skincare product for home use
has been exciting for the company, and we are thrilled that our
scientific findings are contributing to the new field of knowledge
for regenerative aesthetic medicine", says MaryAnn Guerra, ABM's, President/CEO.
Lawrence Rheins Ph.D., Chief Scientific Officer and one of the
authors on the publication, stated, "our ongoing studies
continually provide critical evidence on the growing role of the
platelet in aesthetic medicine and other skin indications. An
additional focus for 2020 will be to evaluate the role of SoME™ as
a simplified anti-aging treatment approach to reduce the current
practice of using multiple skincare product regimens and the value
of using the body's own platelet-rich biomolecules, as the key
source to provide a comprehensive regenerative aesthetic
appearance."
About Aesthetics Biomedical: Aesthetics Biomedical is committed
to the development and distribution of innovative aesthetic
devices, products, and services for the global market. ABM creates
novel patient treatment experiences that ensure our products yield
desired results, keeping patient comfort in mind. Aesthetics
Biomedical's SoME™ products are intended to meet the FDA's
definition of a cosmetic; an article applied to the human body to
cleanse, beautify, promote attractiveness, and alter appearances.
ABM products do not contain platelet rich plasma and are not
intended to be drug or biologic products that diagnose, treat,
cure, or prevent any disease or condition. These products have not
been approved by the FDA, and the statements on these products have
not been evaluated by the FDA.
SOURCE Aesthetics Biomedical